Literature DB >> 9165994

Assessment of anti-endothelial cell antibodies in systemic sclerosis and Sjögren's syndrome.

M Hebbar1, P Lassalle, Y Delneste, P Y Hatron, B Devulder, A B Tonnel, A Janin.   

Abstract

OBJECTIVES: Anti-endothelial cell antibodies (AECA) have been detected in 19 to 30% of patients with systemic sclerosis (SSc). The objective of this study was first to assess the role of a secondary Sjögren's syndrome (SS) in the occurrence of AECA in SSc. Secondly, we researched AECA in patients with primary SS, and investigated whether AECA were associated with vascular manifestations (Raynaud's phenomenon and vasculitis).
METHODS: IgG-AECA were tested by an ELISA method in serum samples from 50 patients with SSc (16 of them had also a secondary SS), 50 patients with primary SS, and 50 healthy controls.
RESULTS: AECA levels were significantly higher in patients with SSc or primary SS than in healthy controls (p < 0.01 and p < 0.01, respectively). In patients with SSc, AECA values were significantly higher in patients with secondary SS (p < 10(-5)). In patients with primary SS, AECA levels were significantly higher in patients with Raynaud's phenomenon (p < 0.01), but not in patients with vasculitis.
CONCLUSION: In patients with SSc, AECA are associated with a secondary SS. In patients with primary SS, AECA are associated with Raynaud's phenomenon, but not with vasculitis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9165994      PMCID: PMC1752356          DOI: 10.1136/ard.56.4.230

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

1.  Histological criteria of Sjögren's syndrome in scleroderma.

Authors:  A Janin; B Gosselin; D Gosset; P Y Hatron; B Sauvezie
Journal:  Clin Exp Rheumatol       Date:  1989 Mar-Apr       Impact factor: 4.473

2.  Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon.

Authors:  D Y Leung; T Collins; L A Lapierre; R S Geha; J S Pober
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

3.  The Copenhagen criteria for Sjögren's syndrome.

Authors:  R Manthorpe; P Oxholm; J U Prause; M Schiødt
Journal:  Scand J Rheumatol Suppl       Date:  1986

Review 4.  The pathophysiology of scleroderma.

Authors:  R Fleischmajer
Journal:  Int J Dermatol       Date:  1977-06       Impact factor: 2.736

5.  Prevalence of Sjögren's syndrome in autoimmune diseases.

Authors:  J Coll; A Rives; M C Griñó; J Setoain; J Vivancos; A Balcells
Journal:  Ann Rheum Dis       Date:  1987-04       Impact factor: 19.103

6.  Early expression of E-selectin, tumor necrosis factor alpha, and mast cell infiltration in the salivary glands of patients with systemic sclerosis.

Authors:  M Hebbar; J M Gillot; E Hachulla; P Lassalle; P Y Hatron; B Devulder; A Janin
Journal:  Arthritis Rheum       Date:  1996-07

7.  The effects of scleroderma serum on human microvascular endothelial cells. Induction of antibody-dependent cellular cytotoxicity.

Authors:  R M Marks; M Czerniecki; B S Andrews; R Penny
Journal:  Arthritis Rheum       Date:  1988-12

8.  Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis.

Authors:  C A Penning; J Cunningham; M A French; G Harrison; N R Rowell; P Hughes
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

9.  Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases.

Authors:  J Rosenbaum; B E Pottinger; P Woo; C M Black; S Loizou; M A Byron; J D Pearson
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

10.  Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.

Authors:  D B Cines; A P Lyss; M Reeber; M Bina; R J DeHoratius
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

View more
  5 in total

Review 1.  Antiendothelial cell antibodies in vasculitis and connective tissue disease.

Authors:  C Belizna; A Duijvestijn; M Hamidou; J W Cohen Tervaert
Journal:  Ann Rheum Dis       Date:  2006-03-28       Impact factor: 19.103

Review 2.  Functional autoantibodies in systemic sclerosis pathogenesis.

Authors:  Angela Kill; Gabriela Riemekasten
Journal:  Curr Rheumatol Rep       Date:  2015-05       Impact factor: 4.592

3.  Atypical presentation of scleroderma in infancy.

Authors:  Navin Mishra; Devendra Shrestha; Rakesh Babu Poudyal; K C Shiva Raj
Journal:  Rheumatol Int       Date:  2011-02-16       Impact factor: 2.631

Review 4.  Lupus mesenteric vasculitis can cause acute abdominal pain in patients with SLE.

Authors:  Ji Hyeon Ju; Jun-Ki Min; Chan-Kwon Jung; Soon Nam Oh; Seung-Ki Kwok; Kwi Young Kang; Kyung-Su Park; Hyuk-Jae Ko; Chong-Hyeon Yoon; Sung-Hwan Park; Chul-Soo Cho; Ho-Youn Kim
Journal:  Nat Rev Rheumatol       Date:  2009-05       Impact factor: 20.543

5.  Soluble markers of B cell activation suggest a role of B cells in the pathogenesis of systemic sclerosis-associated pulmonary arterial hypertension.

Authors:  Sébastien Sanges; Thomas Guerrier; Alain Duhamel; Lucile Guilbert; Carine Hauspie; Alexis Largy; Maïté Balden; Céline Podevin; Guillaume Lefèvre; Manel Jendoubi; Silvia Speca; Éric Hachulla; Vincent Sobanski; Sylvain Dubucquoi; David Launay
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.